MB21

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 562366

CAS#: 1870007-38-7

Description: MB21 is an inhibitor of dengue type 2 protease. It acts by inhibiting each one of the four serotypes of dengue viruses in infected cells in culture.


Chemical Structure

img
MB21
CAS# 1870007-38-7

Theoretical Analysis

MedKoo Cat#: 562366
Name: MB21
CAS#: 1870007-38-7
Chemical Formula: C21H12ClN3O2S
Exact Mass: 405.0339
Molecular Weight: 405.85
Elemental Analysis: C, 62.15; H, 2.98; Cl, 8.73; N, 10.35; O, 7.88; S, 7.90

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: MB21; MB-21; MB 21;

IUPAC/Chemical Name: (E)-4-{5-[2-(5-Chloro-1H-benzoimidazol-2-yl)-2-cyano-vinyl]-thiophen-2-yl}-benzoic acid

InChi Key: KCRGBCOERUHZLY-NTEUORMPSA-N

InChi Code: InChI=1S/C21H12ClN3O2S/c22-15-5-7-17-18(10-15)25-20(24-17)14(11-23)9-16-6-8-19(28-16)12-1-3-13(4-2-12)21(26)27/h1-10H,(H,24,25)(H,26,27)/b14-9+

SMILES Code: O=C(O)C1=CC=C(C2=CC=C(/C=C(C3=NC4=CC(Cl)=CC=C4N3)\C#N)S2)C=C1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 405.85 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Mirza SB, Lee RCH, Chu JJH, Salmas RE, Mavromoustakos T, Durdagi S. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies. J Mol Graph Model. 2018 Jan;79:88-102. doi: 10.1016/j.jmgm.2017.10.010. Epub 2017 Oct 24. PubMed PMID: 29156382.

2: Mirza SB, Lee RCH, Chu JJH, Salmas RE, Mavromoustakos T, Durdagi S. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies. J Mol Graph Model. 2017 Aug 9;77:338. doi: 10.1016/j.jmgm.2017.08.006. [Epub ahead of print] PubMed PMID: 28957754.

3: Oyer JL, Pandey V, Igarashi RY, Somanchi SS, Zakari A, Solh M, Lee DA, Altomare DA, Copik AJ. Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment. Cytotherapy. 2016 May;18(5):653-63. doi: 10.1016/j.jcyt.2016.02.006. PubMed PMID: 27059202.

4: Raut R, Beesetti H, Tyagi P, Khanna I, Jain SK, Jeankumar VU, Yogeeswari P, Sriram D, Swaminathan S. A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture. Virol J. 2015 Feb 8;12:16. doi: 10.1186/s12985-015-0248-x. PubMed PMID: 25886260; PubMed Central PMCID: PMC4327787.

5: Solanki MK, Singh RK, Srivastava S, Kumar S, Kashyap PL, Srivastava AK, Arora DK. Isolation and characterization of siderophore producing antagonistic rhizobacteria against Rhizoctonia solani. J Basic Microbiol. 2014 Jun;54(6):585-97. doi: 10.1002/jobm.201200564. Epub 2013 May 20. PubMed PMID: 23686438.

6: Küçük C, Iqbal J, Hu X, Gaulard P, De Leval L, Srivastava G, Au WY, McKeithan TW, Chan WC. PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20119-24. doi: 10.1073/pnas.1115128108. Epub 2011 Dec 5. PubMed PMID: 22143801; PubMed Central PMCID: PMC3250125.

7: Guo WX, Pye QN, Williamson KS, Stewart CA, Hensley KL, Kotake Y, Floyd RA, Broyles RH. Mitochondrial dysfunction in choline deficiency-induced apoptosis in cultured rat hepatocytes. Free Radic Biol Med. 2005 Sep 1;39(5):641-50. PubMed PMID: 16085182.

8: Bitsch M, Saunte DM, Lohmann M, Holstein PE, Jørgensen B, Gottrup F. Standardised method of surgical treatment of chronic leg ulcers. Scand J Plast Reconstr Surg Hand Surg. 2005;39(3):162-9. PubMed PMID: 16019749.

9: Bom IJ, Klis FM, de Nobel H, Brul S. A new strategy for inhibition of the spoilage yeasts Saccharomyces cerevisiae and Zygosaccharomyces bailii based on combination of a membrane-active peptide with an oligosaccharide that leads to an impaired glycosylphosphatidylinositol (GPI)-dependent yeast wall protein layer. FEMS Yeast Res. 2001 Dec;1(3):187-94. PubMed PMID: 12702343.

10: Shepherd CM, Vogel HJ, Tieleman DP. Interactions of the designed antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid bilayers: molecular-dynamics simulations. Biochem J. 2003 Feb 15;370(Pt 1):233-43. PubMed PMID: 12423203; PubMed Central PMCID: PMC1223151.

11: Moll GN, Brul S, Konings WN, Driessen AJ. Comparison of the membrane interaction and permeabilization by the designed peptide Ac-MB21-NH2 and truncated dermaseptin S3. Biochemistry. 2000 Oct 3;39(39):11907-12. PubMed PMID: 11009603.

12: ter Steeg PF, Hellemons JC, Kok AE. Synergistic actions of nisin, sublethal ultrahigh pressure, and reduced temperature on bacteria and yeast. Appl Environ Microbiol. 1999 Sep;65(9):4148-54. PubMed PMID: 10473428; PubMed Central PMCID: PMC99753.

13: Sherman MI. Long term culture of cells derived from mouse blastocysts. Differentiation. 1975 Aug 11;3(1-3):51-67. PubMed PMID: 1183760.